Bone Marrow TransplantationTransplantation, HomologousBone MarrowHematopoietic Stem Cell TransplantationBone Marrow CellsTransplantation, AutologousGraft vs Host DiseaseStem CellsStem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationHematopoietic Stem CellsTissue DonorsGraft SurvivalKidney TransplantationLeukemiaAnemia, AplasticBone and BonesHistocompatibility TestingHematologic NeoplasmsTransplantation ChimeraHistocompatibilityBusulfanImmunosuppressive AgentsTransplantationTreatment OutcomeGraft RejectionBone Marrow PurgingLiver TransplantationRecurrenceTime FactorsCytomegalovirus InfectionsCyclophosphamideCombined Modality TherapyTransplantation, IsogeneicRetrospective StudiesHeart TransplantationHematopoiesisMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressionImmunocompromised HostHepatic Veno-Occlusive DiseasePeripheral Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteTransplantation ImmunologyPrecursor Cell Lymphoblastic Leukemia-LymphomaCell DifferentiationBone Marrow DiseasesLung TransplantationTransplantsOpportunistic InfectionsCyclosporineRemission InductionAcute DiseaseRadiation ChimeraT-LymphocytesSurvival AnalysisLymphocyte DepletionHematologic DiseasesLeukocyte TransfusionLymphoma, Non-HodgkinHLA AntigensLeukemia, MyeloidEmbryonic Stem CellsSurvival RateBone Marrow ExaminationGraft vs Host ReactionMultiple MyelomaFollow-Up StudiesHematopoietic Stem Cell MobilizationAdult Stem CellsCells, CulturedMyelodysplastic SyndromesFatal OutcomeAntineoplastic Combined Chemotherapy ProtocolsColony-Forming Units AssayFlow CytometryMesenchymal Stem Cell TransplantationLymphocytesBone RemodelingAntigens, CD34ChimeraCord Blood Stem Cell TransplantationAspergillosisBone Marrow NeoplasmsMycosesLymphomaGraft vs Leukemia EffectCytomegalovirusOrgan TransplantationMelphalanGranulocyte Colony-Stimulating FactorPostoperative ComplicationsLymphocyte TransfusionSevere Combined ImmunodeficiencySpleenDisease-Free SurvivalLymphoproliferative DisordersLiving Donors